Glucagon-Like Peptide-1 Receptor Agonists: all 1,407 studies that test it

Page 4 of 15. Open to participants first (306), then studies with results posted, then the rest; newest registration first within each.

• Semaglutide's Efficacy in Achieving Weight Loss for Those With HIVRecruitingNCT04174755Not applicable
• Comparing the Efficacy and Safety Between Continuous Subcutaneous Beinaglutide and CSII for Newly Diagnosed T2DM PatientsRecruitingNCT03987308Not applicable
• Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)RecruitingNCT03884075Phase 2
• Effect of Exercise and/or Liraglutide on Vascular Dysfunction and Insulin Sensitivity in Type 2 Diabetes ( ZQL007)RecruitingNCT03883412Phase 4
• Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD)RecruitingNCT03087032Phase 4
• Safety and Efficacy of Umbilical Cord Blood Regulatory T Cells Plus Liraglutide on Autoimmune DiabetesRecruitingNCT03011021Phase 1/2
• A Drug-Drug Interaction Study of Orforglipron (LY3502970) With Quinidine in Healthy ParticipantsCompletedNCT06704763Phase 1Results posted
• Holding vs. Continuing Incretin-based Therapies Before Upper EndoscopyCompletedNCT06533527Phase 4Results posted
• A Study to Compare Tablets and Capsules of Orforglipron (LY3502970) in Healthy Participants Who Are Obese or OverweightCompletedNCT06440980Phase 1Results posted
• A Drug-Drug Interaction (DDI) Study of Orforglipron With Carbamazepine in Healthy ParticipantsCompletedNCT06370728Phase 1Results posted
• A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With MetforminCompletedNCT06192108Phase 3Results posted
• A Drug-Drug Interaction Study of Orforglipron (LY3502970) in Healthy Overweight and Obese ParticipantsCompletedNCT06186622Phase 1Results posted
• A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 InhibitorCompletedNCT06109311Phase 3Results posted
• A Phase I Study of LY3502970 in Healthy ParticipantsCompletedNCT06085482Phase 1Results posted
• A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With MetforminCompletedNCT06045221Phase 3Results posted
• A Research Study to See How Well Semaglutide Helps People Who Have a Body Weight Above the Healthy Weight RangeCompletedNCT06041217Phase 3Results posted
• A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related ComorbiditiesCompletedNCT06023095Phase 1Results posted
• A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 DiabetesCompletedNCT06010004Phase 3Results posted
• A Study of Tirzepatide (LY3298176) in Healthy Lactating FemalesCompletedNCT05978713Phase 1Results posted
• A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise AloneCompletedNCT05971940Phase 3Results posted
• A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes (SURPASS-CN-MONO)CompletedNCT05963022Phase 3Results posted
• A Phase 1, Parallel, Single-Dose, Open-Label, Single-Period Study of LY3502970 in Participants With Normal Renal Function and Participants With Renal Impairment.CompletedNCT05936138Phase 1Results posted
• A Study of Once-Daily Oral Orforglipron (LY3502970) in Japanese Adult Participants With Obesity DiseaseCompletedNCT05931380Phase 3Results posted
• A Research Study Looking at the Effect of Semaglutide on the Immune System and Other Biological Processes in People With Alzheimer's DiseaseCompletedNCT05891496Phase 3Results posted
• A Study of LY3502970 in Participants With Impaired and Normal Liver FunctionCompletedNCT05882032Phase 1Results posted
• A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 DiabetesCompletedNCT05872620Phase 3Results posted
• A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related ComorbiditiesActive, not recruitingNCT05869903Phase 3Results posted
• A Multiple Dose Study of LY3502970 in Healthy Overweight and Obese ParticipantsCompletedNCT05841238Phase 1Results posted
• A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight With Weight Related ComorbiditiesCompletedNCT05822830Phase 3Results posted
• A Research Study to See How a New Weekly Insulin, Insulin Icodec When Given Along With Semaglutide Helps in Reducing the Blood Sugar Level in Patients With Type 2 DiabetesCompletedNCT05813912Phase 3Results posted
• A Research Study Looking at Similarity Between Tirzepatide Versions for Different Injection DevicesCompletedNCT05810597Phase 1Results posted
• Semaglutide in CFRDCompletedNCT05788965Phase 2/3Results posted
• Effect of GLP1 Receptor Agonists on Physical Function, Body Composition, and Markers of Aging in Older AdultsCompletedNCT05786521Phase 4Results posted
• Pharmacogenomics of GLP1 Receptor AgonistsTerminatedNCT05762744Phase 1Results posted
• A Study of Tirzepatide (LY3298176) in Adults With Type 2 Diabetes Switching From a GLP-1 RA (SURPASS-SWITCH-2)CompletedNCT05706506Phase 4Results posted
• A Study of Tirzepatide (LY3298176) in Pediatric Participants With ObesityCompletedNCT05696847Phase 1Results posted
• A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 DiabetesCompletedNCT05691712Phase 3Results posted
• A Study to Evaluate the Effect of the Experimental GLP-1 Drug PF-07081532 on Blood Levels of Common Birth Control Pills, and Drugs Omeprazole and Midazolam, and Effect of GLP-1 Drug Semaglutide on Midazolam Blood Levels in Healthy Adults With Weight in the Obesity RangeTerminatedNCT05671653Phase 1Results posted
• A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus in IndiaCompletedNCT05659537Phase 4Results posted
• A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose WeightCompletedNCT05649137Phase 3Results posted
• A Research Study to See How Semaglutide Helps People With Excess Weight, Lose Weight (STEP UP)CompletedNCT05646706Phase 3Results posted
• Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or ObeseCompletedNCT05616013Phase 2Results posted
• A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in AmericaCompletedNCT05579249Phase 4Results posted
• A Drug Interaction Study of Cyclosporine and LY3502970 in Healthy ParticipantsCompletedNCT05573230Phase 1Results posted
• Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in People Who Have a Body Weight Above the Healthy RangeCompletedNCT05564117Phase 3Results posted
• A Study of Tirzepatide (LY3298176) in Adult Participants With Type 2 Diabetes Switching From Dulaglutide (SURPASS-SWITCH)CompletedNCT05564039Phase 4Results posted
• Semaglutide Treatment, Appetite, and Eating Behavior: Long-term EffectsCompletedNCT05548647Phase 4Results posted
• ADJUnct Semaglutide Treatment in Type 1 DiabetesCompletedNCT05537233Phase 2Results posted
• Safety Study of Weekly Semaglutide in Chilean Participants With Type 2 DiabetesCompletedNCT05533632Phase 4Results posted
• Effects of Semaglutide on Nicotine IntakeCompletedNCT05530577Phase 2Results posted
• Semaglutide for Alcohol Use DisorderCompletedNCT05520775Phase 2Results posted
• A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE)CompletedNCT05514535Phase 3Results posted
• A Research Study to Look Into How Well Semaglutide Medicine Works at Different Doses in People With Type 2 Diabetes and OverweightCompletedNCT05486065Phase 2Results posted
• A Research Study to Compare Two Semaglutide Medicines in People With Type 2 DiabetesCompletedNCT05478252Phase 3Results posted
• A Drug Interaction Study of Clarithromycin and LY3502970 in Healthy ParticipantsCompletedNCT05469126Phase 1Results posted
• Safety, Tolerability and Pharmacokinetics of Intraarticular 4P004 Single Dose in Patient With KL 2-4 Osteoarthritic KneeCompletedNCT05419856Phase 1Results posted
• Obstructive Sleep Apnea Master Protocol GPIF: A Study of Tirzepatide (LY3298176) in Participants With Obstructive Sleep ApneaCompletedNCT05412004Phase 3Results posted
• A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin IcodecCompletedNCT05352815Phase 3Results posted
• A Study of Two Different Formulations of LY3502970 in Healthy ParticipantsCompletedNCT05341089Phase 1Results posted
• A Study of LY3502970 in Healthy Overweight and Obese ParticipantsCompletedNCT05313802Phase 1Results posted
• Semaglutide Use in Elderly Obese PatientsCompletedNCT05302596Phase 2Results posted
• A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)CompletedNCT05259033Phase 3Results posted
• Effects of GLP1-RA on Ectopic Fat Deposition in Chronic Kidney DiseaseCompletedNCT05254418Phase 2Results posted
• A Research Study Looking at How Well a Combination of the Medicines Semaglutide and NNC0480-0389 Works in People With Type 2 DiabetesCompletedNCT05144984Phase 2Results posted
• Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in East Asian People Who Are Overweight or Living With ObesityCompletedNCT05132088Phase 3Results posted
• A Multiple-Dose Study of LY3502970 in Healthy ParticipantsCompletedNCT05110794Phase 1Results posted
• A Study of LY3502970 in Japanese Participants With Type 2 Diabetes MellitusCompletedNCT05086445Phase 1Results posted
• Semaglutide 2.4 mg in Patients With Poor Weight-lossCompletedNCT05073835Phase 3Results posted
• Research Study Looking at How Well Semaglutide Works in People Suffering From Obesity and Knee OsteoarthritisCompletedNCT05064735Phase 3Results posted
• A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related ComorbiditiesCompletedNCT05051579Phase 2Results posted
• A Study of LY3502970 in Participants With Type 2 Diabetes MellitusCompletedNCT05048719Phase 2Results posted
• Research Study Looking at How Well Semaglutide Works in People Living With Obesity and PrediabetesCompletedNCT05040971Phase 3Results posted
• Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in People Who Are Overweight or Living With Obesity (OASIS 1)CompletedNCT05035095Phase 3Results posted
• A Research Study Comparing RYBELSUS® to Other Blood Sugar Lowering Tablets in People Living in America With Type 2 Diabetes (REALYSE)CompletedNCT05035082Phase 4Results posted
• A Study of Tirzepatide (LY3298176) in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Overweight (SURMOUNT-CN)CompletedNCT05024032Phase 3Results posted
• Research Study Investigating How Well Semaglutide Works in People From Thailand and South Korea Living With ObesityCompletedNCT04998136Phase 3Results posted
• Research Study to Look at How Well Cagrilintide Together With Semaglutide Works in People With Type 2 DiabetesCompletedNCT04982575Phase 2Results posted
• Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)CompletedNCT04971785Phase 2Results posted
• A Research Study to Investigate How Well NNC0165-1875 in Combination With Semaglutide Works in People With ObesityCompletedNCT04969939Phase 2Results posted
• Exenatide for Treating Cocaine Use DisorderCompletedNCT04941521Phase 1/2Results posted
• Liraglutide (Saxenda(R)) in Adolescents With Obesity After Sleeve GastrectomyCompletedNCT04883346Phase 2Results posted
• Liraglutide and Peripheral Artery DiseaseCompletedNCT04881110Phase 4Results posted
• A Research Study to Find Out How Semaglutide Works in the Kidneys Compared to Placebo, in People With Type 2 Diabetes and Chronic Kidney Disease (the REMODEL Trial)CompletedNCT04865770Phase 3Results posted
• Perioperative Stress Hyperglycemia in General and Vascular Surgery PatientsTerminatedNCT04862234Phase 4Results posted
• A Study of Tirzepatide (LY3298176) in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) and Obesity: The SUMMIT TrialCompletedNCT04847557Phase 3Results posted
• A Study of Tirzepatide (LY3298176) in Participants With Obesity DiseaseCompletedNCT04844918Phase 3Results posted
• A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 DiabetesCompletedNCT04809220Phase 3Results posted
• Research Study to Investigate How Well Semaglutide Works in People Living With Heart Failure and ObesityCompletedNCT04788511Phase 3Results posted
• GLP-1 Analogue Effects on Food Cues, Stress, Motivation for Highly Palatable Foods, and WeightCompletedNCT04779697Phase 1Results posted
• A Study to Test Safety and Efficacy of Survodutide (BI456906) in Adults With Non-alcoholic Steatohepatitis (NASH) and Fibrosis (F1-F3)CompletedNCT04771273Phase 2Results posted
• Efficacy of Liraglutide Therapy in Patients With IPAATerminatedNCT04763564Phase 2Results posted
• Effect of Subcutaneous Semaglutide on Kidney Transplant CandidacyTerminatedNCT04741074Phase 3Results posted
• Research Study to Compare Three Doses of Semaglutide Tablets Taken Once Daily in People With Type 2 DiabetesCompletedNCT04707469Phase 3Results posted
• A Study of LY3502970 in Healthy Male ParticipantsCompletedNCT04680767Phase 1Results posted
• A Study to Test Whether Different Doses of BI 456906 Help People With Overweight or Obesity to Lose WeightCompletedNCT04667377Phase 2Results posted
• A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight LossCompletedNCT04660643Phase 3Results posted
• A Study of Tirzepatide (LY3298176) In Participants After A Lifestyle Weight Loss ProgramCompletedNCT04657016Phase 3Results posted
• A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are OverweightCompletedNCT04657003Phase 3Results posted
• Treatment of GLP-1 for Diabetic Bariatric PatientsTerminatedNCT04624672Phase 4Results posted
• A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 DiabetesCompletedNCT04596631Phase 3Results posted

← Glucagon-Like Peptide-1 Receptor Agonists overview